1. Home
  2. RAPT vs MKZR Comparison

RAPT vs MKZR Comparison

Compare RAPT & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • MKZR
  • Stock Information
  • Founded
  • RAPT 2015
  • MKZR 2012
  • Country
  • RAPT United States
  • MKZR United States
  • Employees
  • RAPT N/A
  • MKZR N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • MKZR
  • Sector
  • RAPT Health Care
  • MKZR
  • Exchange
  • RAPT Nasdaq
  • MKZR Nasdaq
  • Market Cap
  • RAPT 122.9M
  • MKZR 10.3M
  • IPO Year
  • RAPT 2019
  • MKZR N/A
  • Fundamental
  • Price
  • RAPT $8.36
  • MKZR $0.67
  • Analyst Decision
  • RAPT Buy
  • MKZR
  • Analyst Count
  • RAPT 5
  • MKZR 0
  • Target Price
  • RAPT $36.75
  • MKZR N/A
  • AVG Volume (30 Days)
  • RAPT 108.9K
  • MKZR 64.8K
  • Earning Date
  • RAPT 08-07-2025
  • MKZR 08-11-2025
  • Dividend Yield
  • RAPT N/A
  • MKZR 52.24%
  • EPS Growth
  • RAPT N/A
  • MKZR N/A
  • EPS
  • RAPT N/A
  • MKZR N/A
  • Revenue
  • RAPT N/A
  • MKZR $23,037,348.00
  • Revenue This Year
  • RAPT N/A
  • MKZR N/A
  • Revenue Next Year
  • RAPT N/A
  • MKZR N/A
  • P/E Ratio
  • RAPT N/A
  • MKZR N/A
  • Revenue Growth
  • RAPT N/A
  • MKZR 52.64
  • 52 Week Low
  • RAPT $5.67
  • MKZR $0.60
  • 52 Week High
  • RAPT $30.60
  • MKZR $5.50
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 54.09
  • MKZR N/A
  • Support Level
  • RAPT $7.89
  • MKZR N/A
  • Resistance Level
  • RAPT $8.43
  • MKZR N/A
  • Average True Range (ATR)
  • RAPT 0.76
  • MKZR 0.00
  • MACD
  • RAPT -0.01
  • MKZR 0.00
  • Stochastic Oscillator
  • RAPT 56.43
  • MKZR 0.00

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About MKZR MacKenzie Realty Capital Inc.

Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.

Share on Social Networks: